Business Wire

OCTO-TELEMATICS

Share
OCTO for the “New Normal”

OCTO, a market leader in providing smart solutions by transforming its IoT Big Data set into actionable intelligence for a sustainable connected life, is pleased to announce the launch of two products designed to support companies' return back to business as they transition to the “new normal” following the COVID-19 pandemic. These innovative solutions encourage safe self-distancing and the robust sanitization of vehicles. At the forefront of the design principals, OCTO developed products are easy to implement and manage, while being highly effective. Protecting the workforce and their livelihoods, as well as protecting customers and fostering higher levels of trust.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200520005174/en/

OCTO AroundMe is based on OCTO’s proven SmartTag technology that utilises the latest Bluetooth standards, OCTO’s IoT cloud platform and is compatible with both iOS and Android smartphones. OCTO AroundMe allows for easy management of social distancing in both public and private spaces, such as stores or office buildings. The pocket-sized SmartTag carried by visitors or employees continuously monitor an individual’s proximity, in this case and under government guidelines this has been automatically set to two metres. Should two people inadvertently have a distance less than two meters apart, an audible alert would remind them to keep a safe distance. The event would also be captured anonymously and stored on the cloud for reporting and analysis, to better understanding and mitigate future risk. To further mitigate any risks, using OCTO AroundMe within closed environments also allows for easy and effective crowd control and building capacity management as it stores all entry and exit information.

OCTO PurePlace uses nano technology originally developed by the National Aeronautics and Space Administration (NASA), that eliminates viruses, bacteria, fungi as well as odours and volatile organic compounds in the air and on surfaces via a purifier. It is a non-invasive solution, safe to people and all materials commonly found within vehicle interiors. As well as the purifier device, the complete OCTO PurePlace solution consists of an onboard telematics device (OCTO SmartDiag or OCTO SuperEasy) and an application compatible with iOS and Android smartphones.

OCTO PurePlace has been designed to protect drivers and passengers across corporate fleets, rental fleets, carsharing and taxi operators. It allows for the easy and effective sanitization of vehicles during a trip with intermittent self-activation and the end of each journey with a full sanitization cycle. To ensure absolute safety and confidence, before entering the vehicle, both the driver and passenger can be notified regarding the state of sanitization via a smartphone app. For the operator and the safe management of the fleet, if the sanitization is not complete, the vehicle may be temporarily suspended from public use.

ABOUT OCTO
Founded in 2002, OCTO is a leading provider of telematic services and advanced data analytics for the insurance sector, and increasingly one of the leading companies offering solutions for Fleet Telematics and Smart Mobility. With OCTO’s unique propositions already established in the field of Insurtech and Smart Mobility, OCTO continues to expand in new sectors and international markets. In the context of an increasingly connected world, OCTO’s advanced analytics and its set of IoT Big Data, generates actionable analytics giving life to a new era of Smart Telematics. Today it has over 6 million connected users and the largest database of vehicle telematics data in the world, with over 267 billion miles of driving data collected and 473,000 claims and insurance events analysed. It also manages over 400,000 vehicle rentals per month.

OCTO does not guarantee, represent or warrant that the use of a photocatalytic oxidation purifier used in the OCTO PurePlace will prevent a vehicle’s occupant(s) from contracting any type of bacteria or virus-based illness, including, but not limited to, the common cold, coronavirus or influenza.

Social Media:

https://www.facebook.com/octotelematicsitalia/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 21:00:00 CET | Press release

Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar

SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 20:35:00 CET | Press release

The Society is welcoming 40 new Fellow Members from across the globe SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support

Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 20:00:00 CET | Press release

Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus

ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 19:30:00 CET | Press release

Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 statusHigh GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impactResults to be presented as a Late-Breaking Abstract Oral Presentation at ASCO GI on January 8, 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on

Siemens and NVIDIA Expand Partnership to Build the Industrial AI Operating System6.1.2026 18:07:00 CET | Press release

Through AI, Siemens and NVIDIA are reinventing the entire end-to-end industrial value chain – from design and engineering to manufacturing, production, operations, and into supply chainsSiemens and NVIDIA to build AI-accelerated portfolio including AI-native electronic design, AI native simulation as well as AI driven adaptive manufacturing and supply chainSiemens and NVIDIA to design the next generation of AI factoriesSiemens and NVIDIA to optimize operations through shared innovation CES 2026 - Siemens and NVIDIA today announced a significant expansion of their strategic partnership to bring artificial intelligence into the real world. Together, the companies aim to develop industrial and physical AI solutions that will bring AI-driven innovation to every industry and industrial workflow, as well as accelerate each others’ operations. To support development, NVIDIA will provide AI infrastructure, simulation libraries, models, frameworks and blueprints, while Siemens will commit hundr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye